Full-Time

Flight Technician

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$117.7k - $162.7k/yr

+ Bonus + Stock-based long-term incentives

Senior, Expert

Thousand Oaks, CA, USA

Category
Flight Dynamics
Materials & Structures
Research & Development
Aerospace Engineering
Requirements
  • Doctorate Degree
  • OR
  • Master's Degree & 3 years of aviation maintenance experience
  • OR
  • Bachelor's Degree & 5 years of aviation maintenance experience
  • OR
  • Associate's degree & 10 years of aviation maintenance experience
  • OR
  • High school diploma/GED & 12 years of aviation maintenance experience
Responsibilities
  • Travel domestically and internationally on corporate aircraft and act as a direct liaison between Corporate Officers and their senior executive staff for the dissemination of sensitive information and critical correspondence while abroad.
  • Perform aircraft maintenance, as required, perform in-depth troubleshooting, manage repairs and certify maintenance in accordance with Federal Aviation Administration rules and regulations ensuring aircraft is certified for continued flight operations.
  • Coordinate all passenger and special handling requirements.
  • Perform the duties as Cabin Attendant.
  • Travel 40% including domestic and international
  • Responsible for the operation and maintenance of onboard aircraft Internet system, telecommunication systems, and audio-visual systems.
  • Responsible for the safety of corporate executives and other passengers
  • Perform advanced troubleshooting/diagnostics of aircraft systems and propose solutions to in-flight emergencies and abnormal technical conditions
  • Plan/procure meals that meet strict dietary needs and order catering
  • Perform the duties of flight safety attendant which will include meal service for passengers and crew members
  • Responsible for safe food handling and storage requirements
  • Conduct aircraft interior and exterior pre-flight and ensuring that all safety, galley and cabin equipment is ready for flight.
  • Work a flexible schedule which includes weekends and holidays
Desired Qualifications
  • FAA Aircraft and Powerplant Certificates
  • 3+ years’ proven experience on maintenance of multi-engine jet aircraft
  • Graduation from a formal maintenance school, military or civilian
  • Preferred aircraft-specific experience G280/G500/G600
  • Completed or be willing to attend the manufacturer’s school on type and category of aircraft in service or two years’ experience on type of aircraft in service
  • Possess a passport, ability to acquire visas and pass a background investigation
  • Cabin service experience

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.